As Drug Discovery Tackles More Difficult Challenges, Lilly Wants To Help

No-Strings Agreements May Evolve To Future Deals

 
• By Mandy Jackson
  
Lilly Gateway Labs San Diego is the big pharma's fifth accelerator site (Alexandria Real Estate Equities Inc.)

More from Start-Ups & SMEs

More from Business